TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 191 filers reported holding TURNING POINT THERAPEUTICS I in Q3 2021. The put-call ratio across all filers is 1.80 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $5,413,000 | +171.6% | 71,942 | -3.1% | 0.00% | +100.0% |
| Q1 2022 | $1,993,000 | -65.4% | 74,233 | -38.5% | 0.00% | -50.0% |
| Q4 2021 | $5,755,000 | +133.2% | 120,638 | +224.8% | 0.00% | +100.0% |
| Q3 2021 | $2,468,000 | +283.8% | 37,143 | +350.3% | 0.00% | – |
| Q2 2021 | $643,000 | -83.7% | 8,249 | -80.3% | 0.00% | -100.0% |
| Q1 2021 | $3,953,000 | +4017.7% | 41,792 | +5217.0% | 0.00% | – |
| Q4 2020 | $96,000 | -47.8% | 786 | -62.7% | 0.00% | – |
| Q3 2020 | $184,000 | +111.5% | 2,105 | +56.9% | 0.00% | – |
| Q2 2020 | $87,000 | -69.3% | 1,342 | -78.9% | 0.00% | – |
| Q1 2020 | $283,000 | -77.7% | 6,352 | -68.8% | 0.00% | – |
| Q4 2019 | $1,269,000 | +24.5% | 20,375 | -24.9% | 0.00% | – |
| Q3 2019 | $1,019,000 | +1098.8% | 27,114 | +1196.1% | 0.00% | – |
| Q2 2019 | $85,000 | – | 2,092 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,392,297 | $291,501,000 | 6.94% |
| Burrage Capital Management LLC | 72,484 | $8,832,000 | 6.73% |
| MPM BioImpact LLC | 617,372 | $75,226,000 | 6.50% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 113,541 | $13,816,000 | 3.77% |
| Orbimed Advisors | 2,745,327 | $334,518,000 | 2.93% |
| SECTORAL ASSET MANAGEMENT INC | 257,379 | $31,362,000 | 2.21% |
| Parkman Healthcare Partners LLC | 59,377 | $7,235,000 | 1.85% |
| Nicholas Investment Partners, LP | 183,676 | $22,381,000 | 1.73% |
| EMERALD ADVISERS, LLC | 357,038 | $43,505,000 | 1.44% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 336,173 | $40,963,000 | 1.42% |